These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 35974701)

  • 1. Human stem cell-derived neurons and neural circuitry therapeutics: Next frontier in spinal cord injury repair.
    Paredes-Espinosa MB; Paluh JL
    Exp Biol Med (Maywood); 2022 Dec; 247(23):2142-2151. PubMed ID: 35974701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of induced pluripotent stem cell-derived motor neuron progenitor cells with irradiated brain-derived neurotrophic factor over-expressing engineered mesenchymal stem cells enhanced restoration of axonal regeneration in a chronic spinal cord injury rat model.
    Kim JW; Kim J; Lee SM; Rim YA; Sung YC; Nam Y; Kim HJ; Kim H; Jung SI; Lim J; Ju JH
    Stem Cell Res Ther; 2024 Jun; 15(1):173. PubMed ID: 38886817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully Characterized Mature Human iPS- and NMP-Derived Motor Neurons Thrive Without Neuroprotection in the Spinal Contusion Cavity.
    Olmsted ZT; Stigliano C; Marzullo B; Cibelli J; Horner PJ; Paluh JL
    Front Cell Neurosci; 2021; 15():725195. PubMed ID: 35046774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
    Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
    Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
    Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
    López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
    Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes migrate from human neural stem cell grafts and functionally integrate into the injured rat spinal cord.
    Lien BV; Tuszynski MH; Lu P
    Exp Neurol; 2019 Apr; 314():46-57. PubMed ID: 30653967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model.
    Nutt SE; Chang EA; Suhr ST; Schlosser LO; Mondello SE; Moritz CT; Cibelli JB; Horner PJ
    Exp Neurol; 2013 Oct; 248():491-503. PubMed ID: 23891888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord.
    Yan J; Xu L; Welsh AM; Hatfield G; Hazel T; Johe K; Koliatsos VE
    PLoS Med; 2007 Feb; 4(2):e39. PubMed ID: 17298165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
    PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.
    Kong D; Feng B; Amponsah AE; He J; Guo R; Liu B; Du X; Liu X; Zhang S; Lv F; Ma J; Cui H
    Stem Cell Res Ther; 2021 Mar; 12(1):172. PubMed ID: 33706803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Preclinical Conditions for Using Adult Human Multipotent Neural Cells in the Treatment of Spinal Cord Injury.
    Won JS; Yeon JY; Pyeon HJ; Noh YJ; Hwang JY; Kim CK; Nam H; Lee KH; Lee SH; Joo KM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury.
    Uezono N; Zhu Y; Fujimoto Y; Yasui T; Matsuda T; Nakajo M; Abematsu M; Setoguchi T; Mori S; Takahashi HK; Komiya S; Nishibori M; Nakashima K
    Stem Cells; 2018 May; 36(5):737-750. PubMed ID: 29517828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
    Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
    Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing CSPG/LAR/PTPσ Axis Facilitates Neuronal Replacement and Synaptogenesis by Human Neural Precursor Grafts and Improves Recovery after Spinal Cord Injury.
    Hosseini SM; Alizadeh A; Shahsavani N; Chopek J; Ahlfors JE; Karimi-Abdolrezaee S
    J Neurosci; 2022 Apr; 42(15):3096-3121. PubMed ID: 35256527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Nakamura M; Okano H; Nagoshi N
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human induced pluripotent stem cell/embryonic stem cell-derived pyramidal neuronal precursors show safety and efficacy in a rat spinal cord injury model.
    Li M; Qi B; Li Q; Zheng T; Wang Y; Liu B; Guan Y; Bai Y; Jian F; Xu ZD; Xu Q; Chen Z
    Cell Mol Life Sci; 2024 Jul; 81(1):318. PubMed ID: 39073571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
    Shibata R; Nagoshi N; Kajikawa K; Ito S; Shibata S; Shindo T; Khazaei M; Nori S; Kohyama J; Fehlings MG; Matsumoto M; Nakamura M; Okano H
    J Neurotrauma; 2022 May; 39(9-10):667-682. PubMed ID: 35196890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.
    Sun L; Wang F; Chen H; Liu D; Qu T; Li X; Xu D; Liu F; Yin Z; Chen Y
    Cell Transplant; 2019 Jul; 28(7):893-906. PubMed ID: 31012325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise combined cell transplantation using mesenchymal stem cells and induced pluripotent stem cell-derived motor neuron progenitor cells in spinal cord injury.
    Kim JW; Kim J; Mo H; Han H; Rim YA; Ju JH
    Stem Cell Res Ther; 2024 Apr; 15(1):114. PubMed ID: 38650015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.